Compare OGN & CMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OGN | CMP |
|---|---|---|
| Founded | 1923 | 1993 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Metals and Minerals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2020 | 2003 |
| Metric | OGN | CMP |
|---|---|---|
| Price | $13.43 | $30.37 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 4 |
| Target Price | $11.40 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 2.6M | 592.2K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.60% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.55 | ★ 0.73 |
| Revenue | ★ $6,216,000,000.00 | N/A |
| Revenue This Year | $0.45 | N/A |
| Revenue Next Year | $1.67 | $1.29 |
| P/E Ratio | ★ $24.42 | $41.89 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.69 | $16.40 |
| 52 Week High | $13.49 | $34.50 |
| Indicator | OGN | CMP |
|---|---|---|
| Relative Strength Index (RSI) | 72.03 | 52.67 |
| Support Level | $10.05 | $27.82 |
| Resistance Level | $13.46 | $32.39 |
| Average True Range (ATR) | 0.05 | 1.40 |
| MACD | -0.11 | -0.21 |
| Stochastic Oscillator | 57.14 | 36.36 |
Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.
Compass Minerals currently produces two primary products: salt and specialty potash fertilizer. The company's main assets include rock salt mines in Ontario, Louisiana, and the United Kingdom. The fertilizer is produced from a brine operation at the Great Salt Lake in Utah that produces sulfate of potash and magnesium chloride. Compass' salt products are used for deicing and also by industrial and consumer end markets. The firm's sulfate of potash is used by growers of high-value crops that are sensitive to standard potash.